Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
Saved in:
| Title: | Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. |
|---|---|
| Authors: | Kim, Jane J.1 (AUTHOR) jkim@hsph.harvard.edu, Simms, Kate T.2,3 (AUTHOR), Killen, James2 (AUTHOR), Smith, Megan A.2,3 (AUTHOR), Burger, Emily A.1,4 (AUTHOR), Sy, Stephen1 (AUTHOR), Regan, Catherine1 (AUTHOR), Canfell, Karen2,3 (AUTHOR) |
| Source: | PLoS Medicine. 3/11/2021, Vol. 18 Issue 3, p1-15. 15p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15491277 |
|---|---|
| DOI: | 10.1371/journal.pmed.1003534 |
